Author: Bertoletti, Antonio; Tan, Anthony T; Le Bert, Nina
Title: The T cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role Cord-id: j0zt5mqi Document date: 2021_2_23
ID: j0zt5mqi
Snippet: SARS-CoV-2, the etiological agent of COVID-19, triggers an adaptive immunity in the infected host that results in the production of virus-specific antibodies and T cells. While kinetic and quantitative aspects of antibodies have been analyzed in large patient cohorts, similar information about SARS-CoV-2-specific T cells are scarce. We summarize in this review the available knowledge of quantitative and temporal features of the SARS-CoV-2 T cell response. Currently, most of the data derived only
Document: SARS-CoV-2, the etiological agent of COVID-19, triggers an adaptive immunity in the infected host that results in the production of virus-specific antibodies and T cells. While kinetic and quantitative aspects of antibodies have been analyzed in large patient cohorts, similar information about SARS-CoV-2-specific T cells are scarce. We summarize in this review the available knowledge of quantitative and temporal features of the SARS-CoV-2 T cell response. Currently, most of the data derived only from the analysis of the circulatory compartment. Despite this limitation, early appearance, multi-specificity and functionality of SARS-CoV-2-specific T cells are associated with accelerated viral clearance and with protection from severe COVID-19.
Search related documents:
Co phrase search for related documents- activation level and adaptive immune response: 1, 2
- activation level and adaptive immunity: 1, 2
- activation level and adaptive innate: 1, 2, 3, 4
- activation level and adaptive innate immunity: 1
- activation level and low peptide specific: 1
- activation marker and acute phase: 1, 2, 3, 4
- activation marker and acute viral infection: 1
- activation marker and adaptive immune response: 1
- activation marker and adaptive immunity: 1, 2, 3, 4
- activation marker and adaptive innate: 1, 2
- activation marker and adaptive innate immunity: 1
- activation marker and lymph node: 1
- activation status and acute phase: 1, 2, 3, 4
- activation status and acute viral infection: 1, 2
- activation status and adaptive immune response: 1, 2
- activation status and adaptive immunity: 1, 2, 3, 4
- activation status and adaptive innate: 1, 2, 3, 4, 5
- activation status and adaptive innate immunity: 1, 2
- activation status and lymph node: 1
Co phrase search for related documents, hyperlinks ordered by date